The National Health Insurance Authority (NHIA) has announced an increase in service tariffs.
The Authority revealed in a statement released on Wednesday, February 1 that a surge in medicinal products as well as medical services has become necessary due to the increase in Active Pharmaceutical Ingredients (APIs).
As a result, framework medicines will be affected with a 50% increase in addition to 30% marginal surge by NHIA.
While non-framework medicines increased by 20%, there will also be a widespread increase in service tariffs by 10%.
The statement also indicated that new medications like Artemether Injection 80mg/ml and Levofloxacin Infusion 500mg/ml will now be part of the list of medicines of the NHIA and will be restored by the National Health Insurance Scheme.
